VANESSA CLOUD: Open Payments
NPI 1053961250 · WILLOWBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,289 in 135 payments from 17 companies in 2025. Trend: 2023 $2,220 · 2024 $2,955 · 2025 $3,289
Food & beverage: $3,114Travel & lodging: $130Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $854 |
| Amgen Inc. | 30 | $774 |
| PFIZER INC. | 18 | $365 |
| Novartis Pharmaceuticals Corporation | 9 | $184 |
| GlaxoSmithKline, LLC. | 7 | $175 |
| E.R. Squibb & Sons, L.L.C. | 2 | $155 |
| Janssen Biotech, Inc. | 6 | $150 |
| Novo Nordisk Inc | 3 | $136 |
| GENZYME CORPORATION | 2 | $122 |
| Genentech USA, Inc. | 5 | $85 |
Products named: RINVOQ, XELJANZ, KRYSTEXXA, SKYRIZI, OTEZLA, BENLYSTA, TREMFYA, Wegovy.
Industry payments across IL — which companies pay providers there.
